Step by Stepa HemeOncBuddy patient portal

Palbociclib

Illustration: Palbociclib

Say it: pal-boh-SY-klib · Brand names: Ibrance

Palbociclib is a targeted therapy pill that helps stop breast cancer cells from dividing.

What it is

Cancer cells use proteins called CDK4 and CDK6 to divide and make more cells. Palbociclib blocks these proteins. It is given with hormone therapy, and the two work better together.

Often used for

How you get it

Palbociclib is taken by mouth at home, once a day. It is usually taken for 3 weeks, followed by 1 week off, and then repeated. Capsules are taken with food; tablets can be taken with or without food. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

At home

Questions to ask

Side effect guides

Sources

Quick answers

What is Palbociclib?
Palbociclib is a targeted therapy pill that helps stop breast cancer cells from dividing. Brand names: Ibrance.
What is Palbociclib used for?
hormone receptor positive, HER2 negative breast cancer that is advanced or has spread, given with hormone therapy.
How is Palbociclib given?
Palbociclib is taken by mouth at home, once a day. It is usually taken for 3 weeks, followed by 1 week off, and then repeated. Capsules are taken with food; tablets can be taken with or without food. Your schedule may be different.
What are the common side effects of Palbociclib?
Low white blood cell counts, which raise your chance of infection. Feeling tired or weak. Feeling sick to your stomach or throwing up. Mouth sores. Hair thinning. Diarrhea. Low red blood cells or platelets.
When should I call my care team while taking Palbociclib?
A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher, or chills; Signs of infection, such as a cough, burning when you pee, or a sore that will not heal; New or worse cough, chest pain, or trouble breathing; Unusual bruising or bleeding.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.